You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669	Sector: Health care
NSE: HESTERBIO	ISIN Code: INE782E01017

BSE 00:00 | 23 Jul

2411.55

-13.75
(-0.57%)

OPEN

2415.00

HIGH

2433.10

LOW

2394.05

NSE 00:00 | 23 Jul

2411.70

-9.10
(-0.38%)

OPEN

2450.00

HIGH

2450.00

LOW

2394.05

Add to Watchlist | Add to Portfolio

OPEN	2415.00
PREVIOUS CLOSE	2425.30
VOLUME	689
52-Week high	3180.00
52-Week low	1246.00
P/E	47.05
Mkt Cap.(Rs cr)	2,052
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

OPEN	2415.00
CLOSE	2425.30
VOLUME	689
52-Week high	3180.00
52-Week low	1246.00
P/E	47.05
Mkt Cap.(Rs cr)	2,052
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

Click here for interactive graph

Hester Biosciences Ltd. (HESTERBIO) - News Sector

Prices of oral diabetes drugs set to fall as patents near expiry date

2.26 pm | 22 Jul 2021 | Business Standard

The diabetes segment has been growing faster than the country's overall drug market
Gland Pharma rallies 8% on strong revenue growth in June quarter

11.16 am | 22 Jul 2021 | Business Standard

Gland Pharma said the growth in revenue was contributed from a mix of launch of new products and volume growth in existing products
Top headlines: Parliament meets, firms face heat on independent valuation

8.51 am | 19 Jul 2021 | Business Standard

Here are the top headlines on Monday morning
Two stock recommendations by Vaishali Parekh: Buy Bata, Wockhardt

8.39 am | 19 Jul 2021 | Business Standard

After a decent correction from the peak level, Wockhardt stock has bottomed out near Rs 520 zone
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

10.44 am | 16 Jul 2021 | Business Standard

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

10.44 am | 16 Jul 2021 | Business Standard

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

10.44 am | 16 Jul 2021 | Business Standard

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

10.44 am | 16 Jul 2021 | Business Standard

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

10.44 am | 16 Jul 2021 | Business Standard

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

10.44 am | 16 Jul 2021 | Business Standard

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

10.44 am | 16 Jul 2021 | Business Standard

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex
KIMS zooms 61% over IPO price as investors lap up shares post listing

3.02 pm | 15 Jul 2021 | Business Standard

Institutional investors purchased an additional 1.24 million equity shares or 1.55 per cent stake of the company via open market post its listing
Sequent Scientific up 9% on EUGMP nod for its tablets dosage form in Turkey

2.21 pm | 15 Jul 2021 | Business Standard

With over 120 product registrations, Sequent is the third-largest player in the Turkish ruminant market with a consolidated market share of around 10 ...
Happiest Minds, Route Mobile: How to trade buzzing stocks of the day

12.11 pm | 15 Jul 2021 | Business Standard

Here's what technical charts suggest regarding the buzzing stocks of the day.
Can produce 250 mn doses of Sputnik V every year: Morepen India CMD

12.30 am | 15 Jul 2021 | Business Standard

The approval of samples, licensing, and final production will take around two months and the vaccine would be available in India for sale also in two ...
BSE IPO index hits new high; Gland Pharma, MTAR zoom over 40% in a month

3.06 pm | 14 Jul 2021 | Business Standard

A total of six stocks -- Angel Broking, CAMS, Gland Pharma, Happiest Minds Technologies, Laxmi Organic and Macrotech Developers -- have hit their resp...
Osho Krishan of Anand Rathi is bullish on these 3 stocks. Do you own any?

8.16 am | 13 Jul 2021 | Business Standard

FDC is in secular uptrend and is in the cycle of higher highs higher lows suggesting inherent strength in the counter
Osho Krishan of Anand Rathi is bullish on these 3 stocks. Do you own any?

8.16 am | 13 Jul 2021 | Business Standard

FDC is in secular uptrend and is in the cycle of higher highs higher lows suggesting inherent strength in the counter
Stocks to watch: Mindtree, Vodafone Idea, RIL, IDBI Bank, Shilpa Medicare

8.01 am | 13 Jul 2021 | Business Standard

Mindtree, Tata Metaliks, Deccan Health Care, Shree Ganesh Remedies and WS Industries are among eight companies that will release quarterly earnings to...
Abbott's Korea-imported PanBio Covid-19 self test launched at Rs 325

11.21 pm | 12 Jul 2021 | Business Standard

Firm expects demand from both, institutions and retail consumers, will import kits in 4-pack sizes from Korean plant; Test linked with NAVICA app whic...